← brief for 2026-08-14 · People & money

Low-dose daratumumab and bortezomib for the treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a case report

Paper D Peer reviewed Preclinical

Key takeaways

A case report of proliferative glomerulonephritis treatment with daratumumab and bortezomib. This study used different dosing or patient groups.

Who did this work

Jiaomei Zhu (Hebei Medical University) · Limin Zhang (Hebei Medical University) · Huibo Zhao (Hebei Medical University) · Li Tian (Hebei Medical University) · Huaying Pei (Hebei Medical University) · Shaomei Li (Hebei Medical University) · Lingling Xing (Hebei Medical University)

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-14
https://doi.org/10.3389/fmed.2026.1899020